Compare Lupin Ltd with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ELDER PHARMA - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ELDER PHARMA LUPIN/
ELDER PHARMA
 
P/E (TTM) x 45.1 -0.2 - View Chart
P/BV x 2.3 0.1 2,289.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   ELDER PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-19
ELDER PHARMA
Jun-14
LUPIN/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs986380 259.5%   
Low Rs720188 383.2%   
Sales per share (Unadj.) Rs369.5491.2 75.2%  
Earnings per share (Unadj.) Rs13.4-3.2 -421.3%  
Cash flow per share (Unadj.) Rs37.414.4 259.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.7376.5 80.7%  
Shares outstanding (eoy) m452.4920.54 2,203.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.30.6 399.4%   
Avg P/E ratio x63.6-89.3 -71.3%  
P/CF ratio (eoy) x22.819.7 115.8%  
Price / Book Value ratio x2.80.8 372.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,0645,833 6,618.2%   
No. of employees `00017.7NA-   
Total wages/salary Rs m31,5132,179 1,446.2%   
Avg. sales/employee Rs Th9,453.8NM-  
Avg. wages/employee Rs Th1,782.0NM-  
Avg. net profit/employee Rs Th343.0NM-  
INCOME DATA
Net Sales Rs m167,18210,089 1,657.1%  
Other income Rs m3,640257 1,418.6%   
Total revenues Rs m170,82210,346 1,651.1%   
Gross profit Rs m28,822-792 -3,639.6%  
Depreciation Rs m10,850361 3,003.1%   
Interest Rs m3,0782,756 111.7%   
Profit before tax Rs m18,534-3,653 -507.4%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4003,713 -91.6%   
Tax Rs m9,017125 7,204.9%   
Profit after tax Rs m6,066-65 -9,281.6%  
Gross profit margin %17.2-7.8 -219.6%  
Effective tax rate %48.7-3.4 -1,420.0%   
Net profit margin %3.6-0.6 -560.1%  
BALANCE SHEET DATA
Current assets Rs m138,5369,240 1,499.3%   
Current liabilities Rs m61,2999,998 613.1%   
Net working cap to sales %46.2-7.5 -615.2%  
Current ratio x2.30.9 244.5%  
Inventory Days Days8446 180.9%  
Debtors Days Days11260 187.6%  
Net fixed assets Rs m127,51610,124 1,259.6%   
Share capital Rs m905206 440.0%   
"Free" reserves Rs m136,5175,582 2,445.5%   
Net worth Rs m137,4227,734 1,777.0%   
Long term debt Rs m66,4174,889 1,358.5%   
Total assets Rs m279,49422,882 1,221.5%  
Interest coverage x7.0-0.3 -2,158.3%   
Debt to equity ratio x0.50.6 76.5%  
Sales to assets ratio x0.60.4 135.7%   
Return on assets %3.311.8 27.8%  
Return on equity %4.4-0.8 -522.3%  
Return on capital %8.922.3 39.9%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m59,414307 19,378.2%   
Fx outflow Rs m22,282125 17,782.9%   
Net fx Rs m37,132181 20,480.8%   
CASH FLOW
From Operations Rs m16,66011,754 141.7%  
From Investments Rs m-32,825-561 5,856.3%  
From Financial Activity Rs m7,441-6,762 -110.0%  
Net Cashflow Rs m-8,7244,432 -196.8%  

Share Holding

Indian Promoters % 46.6 39.6 117.7%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 31.9 16.8 189.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 36.1 28.0%  
Shareholders   98,259 16,479 596.3%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

What Should You Do in Today's Volatile Markets?(Podcast)

The week gone by was pretty volatile for Dalal street and the global environment is as unpredictable as it can get.

Related Views on News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

Small Cap Stocks Could Triple in Less than 2 Years... Here's Why(Profit Hunter)

Sep 30, 2019

Historical data backs up my conviction.

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Sep 30, 2019

Select dividend stocks can be very rewarding.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 11, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS